Recro Pharma Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
12.80
19,682.40
19,779.00
64,483.00
64,482.00
38,514
Total Accounts Receivable
38.40
89.60
8,616.00
10,411.00
9,686.00
18,067
Inventories
-
-
8,982.00
8,746.00
9,839.00
10,699
Other Current Assets
799.90
601.60
757.00
1,118.00
3,276.00
3,861
Total Current Assets
851.10
20,373.60
38,134.00
84,758.00
87,283.00
71,141
Net Property, Plant & Equipment
-
-
37,922.00
37,300.00
39,074.00
45,640
Intangible Assets
-
-
46,462.00
43,879.00
41,296.00
38,712
Other Assets
-
-
542.00
-
-
-
Total Assets
851.10
20,373.60
138,697.00
184,531.00
187,474.00
158,260
ST Debt & Current Portion LT Debt
11,907.20
-
4,516.00
2,236.00
-
Accounts Payable
434.20
-
1,553.00
4,132.00
7,954.00
Income Tax Payable
-
-
86.00
311.00
-
Other Current Liabilities
589.50
1,445.00
3,332.00
9,582.00
41,950.00
Total Current Liabilities
12,931.00
1,445.00
9,487.00
16,261.00
49,904.00
Long-Term Debt
-
-
25,244.00
22,152.00
53,598.00
Provision for Risks & Charges
-
-
59,846.00
69,574.00
50,360.00
Deferred Taxes
-
-
15,637.00
17,060.00
18,573.00
Other Liabilities
-
-
3,770.00
3,397.00
3,516.00
Total Liabilities
12,931.00
1,445.00
98,347.00
112,918.00
158,626.00
Common Equity (Total)
17,959.90
18,928.60
40,350.00
71,613.00
28,848.00
Total Shareholders' Equity
12,079.90
18,928.60
40,350.00
71,613.00
28,848.00
Total Equity
12,079.90
18,928.60
40,350.00
71,613.00
28,848.00
Liabilities & Shareholders' Equity
851.10
20,373.60
138,697.00
184,531.00
187,474.00
Preferred Stock (Carrying Value)
5,880.00
-
-
-
-
About Recro Pharma
View Profile
